Address Confusion About Biosimilars
December 2018
You'll see a growing list of biosimilars.
Nivestym or Zarxio for Neupogen (filgrastim)...Fulphila for Neulasta (pegfilgrastim)...and Inflectra or Renflexis for Remicade (infliximab).
Biosimilars are also approved for Enbrel, Humira, Avastin, and others...but aren't yet available due to legal disputes or other issues.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote